Evidence map›Paper›PMID 34890076›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2022

Stereoselective Synthesis, Configurational Assignment and Biological Evaluations of the Lipid Mediator RvD2

Amalie F Reinertsen, Karoline G Primdahl, Roberta De Matteis, Jesmond Dalli, Trond V Hansen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. FeClChemistryOpen · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amalie F ReinertsenDepartment of Pharmacy, Section for Pharmaceutical Chemistry, University of Oslo, P.O. Box 1068, 0316, Oslo, Norway.ORCID http://orcid.org/0000-0003-0133-7986
Karoline G PrimdahlDepartment of Pharmacy, Section for Pharmaceutical Chemistry, University of Oslo, P.O. Box 1068, 0316, Oslo, Norway.ORCID http://orcid.org/0000-0001-7060-5900
Roberta De MatteisLipid Mediator Unit, Center for Biochemical Pharmacology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, United Kingdom.
Jesmond DalliLipid Mediator Unit, Center for Biochemical Pharmacology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, United Kingdom.ORCID http://orcid.org/0000-0001-6328-3640
Trond V HansenDepartment of Pharmacy, Section for Pharmaceutical Chemistry, University of Oslo, P.O. Box 1068, 0316, Oslo, Norway.ORCID http://orcid.org/0000-0001-5239-9920

Funding

Barts Charity MRC&U0032H2020 European Research Council : 677542
6 · The paper itself

Abstract

Herein we report the first total synthesis of RvD2

Indexed as

Docosahexaenoic AcidsFatty Acids, Omega-3MacrophagesTandem Mass SpectrometryDocosahexaenoic AcidsFatty Acids, Omega-3n-3 docosapentaenoic acidresolution of bacterial infection and inflammationresolvinsRvD2n-3 DPAspecialized pro-resolving mediators

Identifiers

PMID34890076
PMCPMC9305452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.